Replies to post #780983 on NorthWest Biotherapeutics Inc (NWBO)

[Zadie420]

This is great post. My issue is did we complicate the whole process to expand the treatment beyond GBM by increasing the number of pages like 1.7 mil page. Who in right mind will do that to an agency and expect 150 days turn around. Look SMMT with almost $20 bil MC. Look at our pathetic performance in last couple of years. I don't give a damn about the court case. I am only interested in Approval.

[StonkMaster]

Getting harder and harder not to feel this way.

[AllSheWrote]

Dude (dudette?), you need to give serious consideration to your position and vulnerability here. I guess if you can afford to lose it . . .

[Investor082]

I hear you, but wait until it gets to all time lows next month. New set of excuses and theories will start popping next month. Next set of dilution will likely be under .20 (down round from the 17M+ shares diluted at .22 last month).

Flipper has already been positioning for 10 year survival curve. Doc logic and other minions have been positioning for Flaskworks approval (which ain’t happening until 2027/2028 at best). ATL may position for tissue agnostic now, like he was BSing Project Orbis and worldwide approvals 4-5 years ago.

All in all, an excellent opportunity to average down if you are not interested in ROI. On the other hand, if making money is important then taking an opposite bet would be a winning strategy.